Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV003404251 | SCV004103590 | likely pathogenic | IFT140-related disorder | 2023-09-15 | criteria provided, single submitter | clinical testing | The IFT140 c.308_309delCA variant is predicted to result in a frameshift and premature protein termination (p.Thr103Serfs*74). Large study assessing carrier variants for retinitis pigmentosa in genomic databases assessed this variant as likely pathogenic (Table S3, Hanany et al. 2020. PubMed ID: 31964843). This variant is reported in 0.0029% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/16-1652430-CTG-C). Frameshift variants in IFT140 are expected to be pathogenic. This variant is interpreted as likely pathogenic. |
Fulgent Genetics, |
RCV005021939 | SCV005645313 | likely pathogenic | Saldino-Mainzer syndrome; Retinitis pigmentosa 80 | 2024-03-07 | criteria provided, single submitter | clinical testing |